
Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for GastroenterologyBrand Plasil® in the Philippines and Brazil".
Filed with NSE · · 3 pages · English

Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for GastroenterologyBrand Plasil® in the Philippines and Brazil".
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin